Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vifa2g00582 ATGTCAGAACAAGATTATGATTCATGGAGTTTCTTGTTTCTCTGTCTCCTGATCCTTTTCTCAGGTAAACTGGTAGTTGGTGATTCATTGGAAACAGACAAACAAGTACTATTGAAGCTAAAATCGTATTTGCAGAATCAAACAGTTTCGAATAGAGGAGATTACATAAGATGGAACATGAACAATTCAAATCCTTGTGGTTGGTTAGGAATATCATGCAGCATGATCAATGGAGAAACAAGGGTTGTGAGTGTTGATATCTCAGCGAGCCAGATTGCAGGTAAGATGTTTGATCATTTCTCTGAGCTAAGCGAACTCACGCATCTTGATGTCTCGTGGAACACTCTCTGTGGAGAGATTCCTGAGGATTTGAGCAAGTGTGGTAATCTTGTGTATCTCAATTTATCTCATAATATTCTCGAGGGGGAGATGAATTTGACGGGTTTGAGGAAGTTGAGAACATTGGATTTGTCGACGAATAGGCTCCTCGGGGAGATTGGGTTGAGTTTTCGTGATAATTGTGATGGGTTGGTTAGTTTAAATGTTTCGGATAATCACTTTTTTGGTAGGATTGATGAGTGTTTTGATAATTGTTCAAGGTTGAAGTATTTGGATTTGAGTACAAATAATATAAGTGGTGTTTTATGGAATGGGATTTCGAGGTTGACAGAGTTTTCTGTTTCGGAGAATTTTCTAACTGGGAATGTTCCTTCTCGTGCTTTTCCGATGAATTGTAGTCTTGAAAAATTGGATCTTTCTGTCAATGCATTTTTCGGTAAACCGCCTAAGGAAGTTGCTAACTGTAAGAACTTAGAGATTCTAAATCTTTCTAGTAACAAATTTAGCGATGAAATACCTAGTGAAATTGGTTCGATTTCTGGTCTCAAATCACTTTTCTTGCAGAATAACACCTTCTCAAGAGATATTCCAGATACCCTTTTGAATTTGAGCAATTTGTATATTTTGGATGTGAGCAGGAACAACTTTGGTGGTGAGGTACAAGAGATTTTTGGTAAATTCAAGCAATTGAAGTTTCTTTTGTTGCACGCAAATTCTTATGTTAAAGGATTGAATGAATCAGGAATTTTCACATTGAGTAATCTTACAAGATTAAACTTAAGTTTCAACAACTTTTCAGGTCCATTACCAGCTGAAATCTCTCAAATGTCTGGTCTCGTATTCTTAACATTAAGCAACAACAACTTTAATGGAACTATTCCATCTGAATTAGAGAAGTTGAGTAAATTGCAAGCACTTGAACTTGCTTTCAATAGTTTCAGCGGACCAATTCCAGCAAGCTTAGGAAAGTTGAATTCTCTCTTGTGGTTAATGCTTGCAAACAATTCGTTAACCGGTCAAATACCGCACGAGTTAGGTAACTGTTCAAGTTTGTTATGGTTGAACCTTGCAAACAACAAACTCACCGGAATGTTTCCTTCTGAGTTGACCAGAATCGGAAGAAATGCTATGGAGACATTTGAATTAAACCTTAAGAATATGGTTGGTGTTGTGGCTGGAAATAGCGAATGTTTATCGATGAAAAGCTGGATACCTGCTAATTACCCTCCATTCAGTTTTGTGTATAGTATCTTAACACGGAAAAATTGTAGATCCCTTTGGGATAGATTACTCAAAGGATATGGAATTTTTCCAATGTGTGCATCTGAACCTTCGACTAGATCATATCATAAATTCGGTTATGTTCAGTTAAGTGGTAACATGATTAGTGGTGAAATTCCTTCAGAAATTGGGAACATGCTGAATTTTAGTATGTTGCATTTAGGTGACAACAGATTTAACGGCGAATTCCCAAAAGAGATTGGTGGTTTACCACTTATAGTCTTGAACATGACTAGGAACAAATTTTCAGGTGAAATTCCAGAGGAAATCGGTAACATGAAGTGCATGCAGAATCTTGATTTGTCTTGGAACAATTTCTCAGTGCCTCTAACCGGACATTTGCTTACTTTCGATAAAGATTCCTATTTAGGCGATACCCTCTTAGTCCTTCCGAAATTCTTTGATAATAATACCCCAGATGGAAAAAACAAAACATTACACATACATATGAAAAAAGCAACAAAATGTCCGTCTGAGGAACAAGGAAAGTTTCTGAAGGATAAAAACCGGAAGCATAATGATTCAGGTAGCTATGAATCGTCACAGTGGTTATCTGATACCGTCAAGATATTCCATTTGAACAATGTAGTTTTCACGCATGCCGACATTTTGGAAGCAACTAGCAACTTCAAAGAAGAGAGAATCATAGGAAAAGGTGGTTTCGGAACGGTCTTCAAAGGAGTTTTTCCCGATGGAAGAGTAGTGGCAGTGAAGAAGCTACAAAGGGAAGGAACTGAAGGCGAGAAAGAATTCAAAGCTGAAATGAAAGTCCTTAGTGGTCAAGAATTCGGTTGGCCTCATCCAAATCTTGTCACACTTTATGGTTGGTGCTTATACGGTTCACAAAAGTTACTAGTTTACGAGTACATAGGAGGTGGAAGTTTGGAAGAACTAGTAACCGATACAAAAAATTTGACTTATAAAAGGAGGTTAGAAGTCGCTATTGATGTGGCTAAAGCGTTACTTTATCTACACCATGAATGTTACCCTCCAATCGTGCATAGAGATGTGAAGGCTAGTAACGTGTTGCTTGACAAAGAAGGTAAAGCAAAAGTAACAGATTTCGGGCTTGCTAGAGTAGTCAATGTTGGTGATAGCCACGTGAGTACAGTTGTTGCTGGAACTGTCGGATATGTTGCACCTGAATATGGACAAACATGGCAAGCGACAACAAAAGGCGATGTGTATAGTTTTGGGGTGTTGATCATGGAGTTAGCGACTGGGAGAAGAGCTGTGGATGGAGGTGAAGAATGTTTGGTTGAATGTGTTAGGCGTGTGATTGGTTCTGGTAGAAATGGATTGAGTCATTTTGGGTTAGTTGGTGGTGCAAAAGAGATGTTTGAGTTGCTTTTTGTTGGAGTGAAGTGCACAAATGACTCGCCACATAATAGGCCTAACATGAAAGAGGTTCTAGCTATGTTGATTAAGATATTCAATTCTCATAGAAATTCAAACTATTAA 3081 0.3801 MSEQDYDSWSFLFLCLLILFSGKLVVGDSLETDKQVLLKLKSYLQNQTVSNRGDYIRWNMNNSNPCGWLGISCSMINGETRVVSVDISASQIAGKMFDHFSELSELTHLDVSWNTLCGEIPEDLSKCGNLVYLNLSHNILEGEMNLTGLRKLRTLDLSTNRLLGEIGLSFRDNCDGLVSLNVSDNHFFGRIDECFDNCSRLKYLDLSTNNISGVLWNGISRLTEFSVSENFLTGNVPSRAFPMNCSLEKLDLSVNAFFGKPPKEVANCKNLEILNLSSNKFSDEIPSEIGSISGLKSLFLQNNTFSRDIPDTLLNLSNLYILDVSRNNFGGEVQEIFGKFKQLKFLLLHANSYVKGLNESGIFTLSNLTRLNLSFNNFSGPLPAEISQMSGLVFLTLSNNNFNGTIPSELEKLSKLQALELAFNSFSGPIPASLGKLNSLLWLMLANNSLTGQIPHELGNCSSLLWLNLANNKLTGMFPSELTRIGRNAMETFELNLKNMVGVVAGNSECLSMKSWIPANYPPFSFVYSILTRKNCRSLWDRLLKGYGIFPMCASEPSTRSYHKFGYVQLSGNMISGEIPSEIGNMLNFSMLHLGDNRFNGEFPKEIGGLPLIVLNMTRNKFSGEIPEEIGNMKCMQNLDLSWNNFSVPLTGHLLTFDKDSYLGDTLLVLPKFFDNNTPDGKNKTLHIHMKKATKCPSEEQGKFLKDKNRKHNDSGSYESSQWLSDTVKIFHLNNVVFTHADILEATSNFKEERIIGKGGFGTVFKGVFPDGRVVAVKKLQREGTEGEKEFKAEMKVLSGQEFGWPHPNLVTLYGWCLYGSQKLLVYEYIGGGSLEELVTDTKNLTYKRRLEVAIDVAKALLYLHHECYPPIVHRDVKASNVLLDKEGKAKVTDFGLARVVNVGDSHVSTVVAGTVGYVAPEYGQTWQATTKGDVYSFGVLIMELATGRRAVDGGEECLVECVRRVIGSGRNGLSHFGLVGGAKEMFELLFVGVKCTNDSPHNRPNMKEVLAMLIKIFNSHRNSNY 1026
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vifa2g00582 1026 Gene3D Phosphorylase Kinase; domain 1 713 829 - -
Vifa2g00582 1026 Pfam Leucine rich repeat N-terminal domain 31 74 IPR013210 -
Vifa2g00582 1026 Gene3D Ribonuclease Inhibitor 334 684 IPR032675 -
Vifa2g00582 1026 FunFam Putative LRR receptor-like serine/threonine-protein kinase 342 502 - -
Vifa2g00582 1026 CDD STKc_IRAK 756 1017 - -
Vifa2g00582 1026 Gene3D Ribonuclease Inhibitor 243 333 IPR032675 -
Vifa2g00582 1026 ProSitePatterns Serine/Threonine protein kinases active-site signature. 872 884 IPR008271 GO:0004672|GO:0006468
Vifa2g00582 1026 Gene3D Transferase(Phosphotransferase) domain 1 831 1025 - -
Vifa2g00582 1026 Pfam Leucine Rich repeat 366 380 IPR001611 GO:0005515
Vifa2g00582 1026 Pfam Leucine Rich repeat 198 213 IPR001611 GO:0005515
Vifa2g00582 1026 Pfam Leucine Rich repeat 268 284 IPR001611 GO:0005515
Vifa2g00582 1026 FunFam Leucine-rich repeat receptor protein kinase MSP1 712 829 - -
Vifa2g00582 1026 ProSitePatterns Protein kinases ATP-binding region signature. 756 779 IPR017441 GO:0005524
Vifa2g00582 1026 FunFam Leucine-rich repeat receptor-like protein kinase 830 1025 - -
Vifa2g00582 1026 SMART serkin_6 750 1018 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g00582 1026 SMART LRR_typ_2 292 316 IPR003591 -
Vifa2g00582 1026 SMART LRR_typ_2 437 461 IPR003591 -
Vifa2g00582 1026 SMART LRR_typ_2 149 172 IPR003591 -
Vifa2g00582 1026 SMART LRR_typ_2 365 389 IPR003591 -
Vifa2g00582 1026 SMART LRR_typ_2 103 127 IPR003591 -
Vifa2g00582 1026 SUPERFAMILY L domain-like 219 652 - -
Vifa2g00582 1026 FunFam LRR receptor-like serine/threonine-protein kinase GSO1 76 341 - -
Vifa2g00582 1026 Gene3D Ribonuclease Inhibitor 172 242 IPR032675 -
Vifa2g00582 1026 PANTHER LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED 245 1016 - -
Vifa2g00582 1026 MobiDBLite consensus disorder prediction 698 715 - -
Vifa2g00582 1026 FunFam LRR receptor-like serine/threonine-protein kinase ERECTA 558 650 - -
Vifa2g00582 1026 Pfam Protein kinase domain 750 954 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g00582 1026 Gene3D Ribonuclease Inhibitor 29 171 IPR032675 -
Vifa2g00582 1026 SUPERFAMILY L domain-like 62 311 - -
Vifa2g00582 1026 MobiDBLite consensus disorder prediction 698 717 - -
Vifa2g00582 1026 SUPERFAMILY Protein kinase-like (PK-like) 731 1014 IPR011009 -
Vifa2g00582 1026 ProSiteProfiles Leucine-rich repeat profile. 129 150 IPR001611 GO:0005515
Vifa2g00582 1026 ProSiteProfiles Protein kinase domain profile. 750 1018 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vifa2g00582 1026 Pfam Leucine Rich Repeat 106 127 IPR001611 GO:0005515
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vifa2g00582 Vifa-Chr2 122251714 122255183 Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vifa2g00582 11 1014 Receptor kinase-like Gene Family AT1G55610 31.271 1.34e-142 455
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-Xb-2 Vifa2g00582 Pkinase 2.2e-44 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vifa2g00582 - - gmx:100813425 1480.31